Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
R Safaei, BJ Larson, TC Cheng, MA Gibson… - Molecular cancer …, 2005 - AACR
Previous work has shown that cisplatin (CDDP) becomes concentrated in lysosomes, and
that acquired resistance to CDDP is associated with abnormalities of protein trafficking and …
that acquired resistance to CDDP is associated with abnormalities of protein trafficking and …
Scarless fetal wound healing: a basic science review
BJ Larson, MT Longaker, HP Lorenz - Plastic and reconstructive …, 2010 - journals.lww.com
Scar formation is a major medical problem that can have devastating consequences for
patients. The adverse physiological and psychological effects of scars are broad, and there are …
patients. The adverse physiological and psychological effects of scars are broad, and there are …
Calcium-based nanoparticles accelerate skin wound healing
K Kawai, BJ Larson, H Ishise, AL Carre, S Nishimoto… - PloS one, 2011 - journals.plos.org
Introduction Nanoparticles (NPs) are small entities that consist of a hydroxyapatite core, which
can bind ions, proteins, and other organic molecules from the surrounding environment. …
can bind ions, proteins, and other organic molecules from the surrounding environment. …
Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells
R Safaei, K Katano, BJ Larson, G Samimi… - Clinical cancer …, 2005 - AACR
Purpose: We sought to identify the subcellular compartments in which cisplatin [cis-diamminedichloroplatinum
(DDP)] accumulates in human ovarian carcinoma cells and define its …
(DDP)] accumulates in human ovarian carcinoma cells and define its …
Transport of cisplatin by the copper efflux transporter ATP7B
ATP7B is a P-type ATPase that mediates the efflux of copper. Recent studies have demonstrated
that ATP7B regulates the cellular efflux of cisplatin (DDP) and controls sensitivity to the …
that ATP7B regulates the cellular efflux of cisplatin (DDP) and controls sensitivity to the …
Global burden of cardiovascular disease
…, C Cowan, R Healicon, I Robson, WR Long, J Barrett… - 2013 - heart.bmj.com
… GM Fröhlich, J Holzmeister, M Hübler, S Hübler, M Wolfrum, F Enseleit, B Seifert, D
Hürlimann, HB Lehmkuhl, G Noll, J Steffel, V Falk, TF Lüscher, R Hetzer, F Ruschitzka … C …
Hürlimann, HB Lehmkuhl, G Noll, J Steffel, V Falk, TF Lüscher, R Hetzer, F Ruschitzka … C …
Fetal mouse skin heals scarlessly in a chick chorioallantoic membrane model system
AL Carre, BJ Larson, JA Knowles, K Kawai… - Annals of plastic …, 2012 - journals.lww.com
In mammals, the early-gestation fetus has the regenerative ability to heal skin wounds
without scar formation. This observation was first reported more than 3 decades ago, and has …
without scar formation. This observation was first reported more than 3 decades ago, and has …
Precision in Prevention: Tailoring Single-Use Negative Pressure Wound Therapy Utilization Through Artificial Intelligence-Based Surgical Site Complications Risk and …
BJ Larson, A Roakes, S Yurick, NA Netravali - Surgical Infections, 2024 - liebertpub.com
Background: Surgical site complications (SSCs) are common, yet preventable hospital-acquired
conditions. Single-use negative pressure wound therapy (sNPWT) has been shown to …
conditions. Single-use negative pressure wound therapy (sNPWT) has been shown to …
Using wearable technology to optimize maternal positioning and facilitate progression of labor
BJ Larson, D Mejia, T Marquez, P Reinhard - Journal of Obstetric …, 2016 - jognn.org
Purpose for the Program Epidural analgesia has been shown to pro-long labor and increase
the risk of instrumental delivery. It is well established that frequent repositioning can …
the risk of instrumental delivery. It is well established that frequent repositioning can …
Acquired resistance to cisplatin is accompanied by the increased export of secretory and lysosomal components via exosomes
1481 We have previously documented that the intracellular sequestration and trafficking of
cisplatin (DDP) is altered in DDP-resistant ovarian carcinoma cells. In this study we examined …
cisplatin (DDP) is altered in DDP-resistant ovarian carcinoma cells. In this study we examined …